Skip to main content
. 2024 Jan 4;73(1):4. doi: 10.1007/s00262-023-03583-4

Fig. 1.

Fig. 1

Kaplan–Meier survival curves of TTD (A), PFS (B), and OS (C) in the NICT and PCT groups after propensity score matching. Abbreviations: NICT, nivolumab plus ipilimumab with chemotherapy; PCT, pembrolizumab with chemotherapy; mTTD, median time to treatment discontinuation; mPFS, median progression-free survival; mOS, median overall survival; HR, hazard ratio